MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
Ontology highlight
ABSTRACT: Clear cell renal cell carcinoma (ccRCC) is the most prevalent adult kidney cancer. Prognostic markers are needed to guide patient management toward aggressive versus more conservative approaches, especially for small tumors ≤4 cm. miR-194 was reported to be downregulated in several cancers and is involved in epithelial to mesenchymal transition. We evaluated miR-194 as a prognostic marker in ccRCC. In a cohort of 234 patients with primary ccRCC, we correlated miR-194 expression level with multiple clinicopathological features including disease-free and overall survival, tumor size, clinical stage, and histological grade. Our results shows a stepwise decrease in miR-194 expression from normal kidney to primary ccRCC (P = 0.0032) and a subsequent decrease from primary to metastatic lesions.
SUBMITTER: Nofech-Mozes R
PROVIDER: S-EPMC4831284 | biostudies-literature | 2016 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA